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Abstract
Background: The two variants of the a-form of the catalytic (C) subunit of protein kinase A (PKA), designated Ca1
and Ca2, are encoded by the PRKACA gene. Whereas Ca1 is ubiquitous, Ca2 expression is restricted to the sperm
cell. Ca1 and Ca2 are encoded with different N-terminal domains. In Ca1 but not Ca2 the N-terminal end
introduces three sites for posttranslational modifications which include myristylation at Gly1, Asp-specific
deamidation at Asn2 and autophosphorylation at Ser10. Previous reports have implicated specific biological
features correlating with these modifications on Ca1. Since Ca2 is not modified in the same way as Ca1 we tested
if they have distinct biochemical activities that may be reflected in different biological properties.
Results: We show that Ca2 interacts with the two major forms of the regulatory subunit (R) of PKA, RI and RII, to
form cAMP-sensitive PKAI and PKAII holoenzymes both in vitro and in vivo as is also the case with Ca1. Moreover,
using Surface Plasmon Resonance (SPR), we show that the interaction patterns of the physiological inhibitors RI, RII
and PKI were comparable for Ca2 and Ca1. This is also the case for their potency to inhibit catalytic activities of
Ca2 and Ca1.
Conclusion: We conclude that the regulatory complexes formed with either Ca1 or Ca2, respectively, are
indistinguishable.
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Background
Cyclic 3’, 5’-adenosine monophosphate (cAMP) is a key
intracellular signaling molecule, whose main function is
to activate the cAMP-dependent protein kinase (PKA)
[1]. PKA is a heterotetrameric holoenzyme consisting of
a regulatory (R) subunit dimer and two catalytic (C)
subunits. The holoenzyme is activated when four mole-
cules of cAMP bind to the R subunit dimer, two to each
R subunit, releasing two free active C subunits [2;3]. In
man, four different R subunits designated RIa, RIb RIIa,
RIIb (reviewed in [4]), and four different C subunits
(Ca, Cb, Cg and PrKX) have been identified [3]. The Ca
and Cb subunits are expressed in most tissues, while the
Cg subunit, which is transcribed from an intron-less
gene, represents a retroposon derived from the Ca sub-
unit [5]. Cg is only expressed in human testis [6]. PrKX
is an X chromosome-encoded protein kinase, and was
identified as a PKA C subunit since it is inhibited by
both PKI and RIa, and the RIa/PrKX complex is acti-
vated by cAMP [7].
Splice variants of both Ca and Cb have been identi-
fied. In the case of Ca, two splice variants have been
identified and termed Ca1 [8] and Ca2 [9-11]. Ca1 and
Ca2 have non-identical N-terminal ends encoded by
alternative use of two exons (1a and 1b, mouse termi-
nology) located upstream of exon 2 in the murine Ca
gene. The Cb gene encodes a number of products iden-
tified in various species and have been designated Cb1,
Cb2, Cb3, Cb4, Cb3ab, Cb3b, Cb3abc, Cb4ab, Cb4b,
Cb4abc [12-17]. As is the case for the Ca forms, all the
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Cb variants have variable N-terminal ends which are
encoded by different exons upstream of exon 2 in the
Cb gene [14;15].
PKA-C splice variants are tissue-specifically expressed
and some experimental evidence support that they may
harbor specific features and non-identical activities
when associated with the R subunits to form holoen-
zymes [18;19]. With regard to this Ca2 it is the sole C
subunit expressed in the sperm cell. Moreover, Ca2 was
shown to be vital for mouse sperm motility since abla-
tion rendered the sperm cells non-motile and the male
individuals infertile [9-11;20].
Ca1 is equipped with an N-terminal of 14 amino acids
which undergo three well defined co- and posttransla-
tional modifications. They include in vivo myristylation
of Gly1 [21]. At position +1 an Asn is encoded which is
partly deamidated in vivo leading to Ca1-Asp2 and
Ca1-iso(b)Asp2 [22]. A third modification is identified
as a PKA-autophosphorylation site at Ser10 [23-25].
Ca2 on the other hand is encoded with 7 unique amino
acids at the N-terminus which to our knowledge do not
have the ability to undergo any of the N-terminal modi-
fications seen for Ca1.
Based on the different N-terminal sequences of Ca1
and Ca2 we speculate that they will introduce distinct
biological features to these subunits. To investigate this
hypothesis we made a thorough characterization of Ca2
activities both in vivo and in vitro and compared the
results to what is known for Ca1 and to results
obtained for Ca1 in the present work.
Methods
Sperm cell isolation
Semen samples were obtained from patients attending
infertility investigations at the Andrology Laboratory at
Rikshospitalet-Radiumhospitalet HF, Oslo, Norway. All
patients signed a letter of approval and all experiments
were done according to the recommendation from the
Regional Committees for Medical and Health Research
Ethics. All men produced their ejaculates on site or at
home after 3-5 days of sexual abstinence. Samples were
collected by masturbation into a wide-mouthed sterile
container (Sarstedt Ltd., Leicester, United Kingdom) and
after 30 min of liquefaction at 37°C, sperm parameters
were evaluated according to World Health Organization
(WHO) methods (World Health Organization, WHO
laboratory manual for the examination of human semen
and sperm-cervical mucus interaction (4th ed.), Cam-
bridge University Press, Cambridge (1999).
Sperm cells were isolated from the seminal plasma by
percoll gradient centrifugation. Sperm samples were
pipetted on top of a 90%/45% percoll gradient and cen-
trifuged at 2500 rpm for 20 min, no brake. After centri-
fugation, the sperm pellet was recovered by first using a
sterile glass Pasteur pipette to remove the top layers of
the semen sample and sperm gradient, leaving approxi-
mately 0.5 mL of the bottom layer. The sperm pellet
was subsequently resuspended and washed twice in
phosphate buffered saline (PBS) and centrifuged again at
2500 rpm for 8 min.
Sperm head and tail separation
Isolated sperm cells were diluted to 1 mill/mL in PBS
and sonicated mildly for 10 sec at low frequency. Ten
μL samples were taken out to be examined by micro-
scopy to assure head and tail separation. After complete
separation the mixture was centrifuged at 400 g for 10
min. The supernatant containing the tails was trans-
ferred to a new tube and tails pelleted by centrifugation
at 10.000 × g for 15 min. The tail pellet and the pellet
from the first centrifugation were separately solubelized
in RIPA buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA,
1% Triton X-100, 0.1% SDS, 0.1% Na-deoxycholate and
100 mM NaCl) containing 1 mM DTT, 1 mM PMSF
and protease inhibitor cocktail (Roche), and sonicated 2
× 10 seconds at full effect.
SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE, was performed as described by [26]. Briefly,
samples were diluted in SDS sample buffer (62.5 mM
Tris-HCl, pH 6.8, 2.3% SDS, 10% glycerol, 5% b-mercap-
toethanol, 0.001% bromophenol blue), boiled for 2 min
and loaded onto slab gels consisting of a 4.5% stacking
gel and a 12.5% separating gel.
Immunoprecipitation
Lysates were cleared by centrifugation at 15000 g for 30
min at 4°C, and subsequently incubated with primary
antibody [anti-Ca2 (SNO101; 320 μg/mL), mouse anti-
RIa (2.5 μg/mL), rabbit anti-RIIa serum diluted 1:100]
for 2 h to overnight. Antibody-antigen complexes were
precipitated using either Dynabeads protein G (Dynal,
catalogue number 100.04), anti-mouse agarose beads or
anti-rabbit agarose beads (Sigma, catalogue number
A6531, A1027). Precipitates were washed three times
using appropriate buffer and extracted with buffer in the
presence or absence of 1 mm 8-CPT cAMP as indicated
in the figure legends.
Immunoblot analysis
Total protein was estimated by Bradford protein assay
(BioRad). Proteins were separated by SDS-PAGE and
transferred to PVDF membranes by electro blotting.
Membranes were blocked in 5% skimmed milk powder
in Tris-buffered saline containing 0.1% Tween-20
(TBST) for 1 h at room temperature, and then incu-
bated for 1 h at room temperature or overnight at 4°C
with the appropriate primary antibodies diluted in TBST
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rabbit polyclonal anti-C 1:1000 (Santa Cruz Biotechnol-
ogy), anti-Ca2 (SNO101), mouse anti-RIa 1:250 and
rabbit anti-RIIa serum [27]. Membranes were washed
for about 1 h in TBST and further incubated with HRP-
conjugated secondary antibodies (ICN Diagnostics).
Membranes were washed and finally developed using
SuperSignal© West Pico Chemiluminescent (Pierce).
Endogenous sperm cell protein fractionation
Sperm cells were homogenized in PE buffer (5 mM
KH2PO4, 5 mM K2HPO4, 1 mM EDTA, pH 6.8) con-
taining 0.5% Triton X-100, 1 mM DTT, 1 mM PMSF
and protease inhibitor cocktail (Roche), and sonicated 2
× 10 seconds. DEAE cellulose (Whatman DE 52) was
applied to a column and equilibrated with PE buffer
with 250 mM sucrose. The sperm cell homogenates
were cleared by centrifugation at 15.000 g for 30 min at
4°C and applied to the column. After washing with PE
buffer, the column was eluted with a linear 0-400 mM
NaCl gradient created by a gradient mixer (total volume
50 ml), 1 ml fractions were collected and salt concentra-
tion checked by refractometry. Every other fraction,
starting with fraction 1 was subjected to phosphotrans-
ferase activity measurements in the absence and pre-
sence of cAMP. Peak fractions were concentrated to 100
μl using centrifugal filters with 30 kDa cutoff (Millipore)
and subjected to immunoblot analysis.
Phosphotransferase assay
Catalytic activity of PKA was assayed by phosphorylating
the PKA specific substrate Kemptide (Peninsula) using g-
[32P]ATP (5000 mCi/μmol) as previously described [26].
Specific activity is determined as U/mg, which is
defined as μmol/mg × min.
cAMP-binding assay
Determination of specific cAMP-binding of soluble R
subunits was carried out in a buffer containing 0.3 μmol
[3H]-cAMP (spec. act. 41.7 Ci/mmol, Amersham) [27].
Activation Assay
The activation assay of Ca2 and myrCa1 with RIa and
RIIb, respectively, was performed in a spectrophoto-
metric kinase activity assay as described earlier [28].
Expression of Ca2, Ca1 and myristylated Ca1
Recombinant non-myristylated human Ca1 was
expressed and purified as described previously [29;30].
Recombinant human Ca1, as well as recombinant
human Ca2, were co-transformed with N-myristyl-trans-
ferase in Escherichia coli BL21 (DE3) (Novagen) and co-
expressed with human Ca1 as well as Ca2 using the
same conditions. Both proteins were purified by affinity
chromatography using PKI-peptide Affi-Gel. The
procedure was first described by Olsen et al. [31] and
modified after Thullner et al. [32].
Expression and purification of R subunits
Recombinant human R subunits (hRIa, hRIb, hRIIa,
hRIIb) were over-expressed in Escherichia coli BL21
(DE3) RIL (Novagen) and purified according to a proce-
dure by Bertinetti et al. [33] using Sp-8-AEA-cAMPS-
agarose.
The purity of the R and C proteins was confirmed by
SDS-PAGE as well as by immunoblot analysis and the
biological activity of the proteins was measured as
described before [30]. Primary sequence of Ca2 and the
presence of N-myristylation at Ca1 were checked by
mass spectrometry (Data not shown).
SPR analysis
All SPR interaction analyses were performed at 25°C in
20 mM MOPS pH 7, 150 mM NaCl plus 0.005% (v/v)
surfactant P20, 1 mM ATP, 5 mM MgCl2 and 50 μM
EDTA using Biacore 2000 or 3000 instruments (GE
Healthcare-Biacore, Sweden). For covalent coupling of
the C subunits, carboxymethylated sensor chip surfaces
(CM5, research grade, GE Healthcare) were activated
with NHS/EDC for 7 min and non-myristylated Ca1,
Ca2 and myrCa1 (5 μg/μl in 10 mM sodium acetate
plus 200 μM ATP and 500 μM MgCl2 with a pH 6.0) as
described [34] were injected on separate flow cells with
a flow rate of 5 μl/min until approximately 300 response
units (RU 1,000 RU = 1 ng/mm2 for a CM 5 chip) [35]
were reached. This amine coupling was described pre-
viously [36;37]. Deactivation of the surface was per-
formed using 1 M ethanolamine-HCl (pH 8.5) for 7
min. As a reference one flow cell was activated and
deactivated in the absence of any protein.
The interaction experiments with four R subunit were
performed at 25°C in running buffer (20 mM MOPS pH
7, 150 mM NaCl, 1 mM ATP, 5 mM MgCl2, 50 μM
EDTA, 0.005% surfactant P20) at a flow rate of 30 μl/
min. During simultaneous R subunit injection over the
four surfaces (150 sec), the dissociation phase was moni-
tored for 150 sec. The binding of R subunit to C subunit
was not limited by mass transport according to previous
experiments [38]. Response of the activated/deactivated
reference cell was subtracted. Surfaces were regenerated
with two subsequent 1 min injections of 0,1 mM cAMP,
2,5 mM EDTA in running buffer. Evaluation of non-
normalized data was performed with Biaevaluation 3.2
RC1 (GE Healthcare). A Langmuir 1:1 binding model
was applied for the kinetic analysis of C subunit/R subu-
nit interactions [37].
The sensor chip was stored at 4°C in running buffer
and tested for proper performance prior to each
analysis.
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Results
Sperm cell-specific Ca2 associates with RIa and RIIa in a
cAMP-dependent fashion to form PKAI and PKAII
holoenzymes in vivo
We first determined whether human sperm cells express
Ca2. Protein extracts of T cells, whole sperm, sperm
tail, and sperm heads were separated by SDS-PAGE
transferred to immunoblot filters and filters probed with
a pan-C antibody (Figure 1A, left panel, anti-C) and an
anti-Ca2 antiserum (SNO 101, anti-Ca2 [10], Figure
1A, right panel). This confirms previous results that
Ca2 is not expressed in T cells and is distributed in tail
and head of spermatozoa [10]. RI and RII are both
expressed in all sperm cell compartments and are
known to form PKA type I and type II (PKAI and
PKAII) [39-41]. PKAI and PKAII holoenzymes can be
separated by DEAE ion exchange chromatography using
increasing concentrations of NaCl [42]. Since Ca2 is the
sole C subunit in human sperm cells it is expected that
it will associate with RI and RII to form PKAI and
PKAII, respectively, as has been demonstrated in the
mouse [11]. To test this, whole sperm cell extracts (3
mg) were fractionated on DEAE resins by a linear NaCl
gradient ranging from 0 to 350 mM). Two peaks of
phosphotransferase- (–●–) and cAMP-binding activity
(–□–) between 50-100 mM and 100-250 mM NaCl,
respectively, were observed. This implied formation of
both PKAI and PKAII (Figure 1B). C and R subunit
identity were documented by immunoblotting using a
pan-C antibody (Figure 1, panel CI) and anti-Ca2 (panel
CII) as well as anti-RIa (panel CIII) and anti-RIIa
(panel CIV). This showed that immunoreactive Ca2 co-
elutes with the two major R subunits in sperm cells, RIa
(peak I) and RIIa (peak II) [43-45]. From the figure it is
also seen that some of the C activity was detected before
the R subunit activity in the first peak, implying free C
subunit. Moreover, we also noted that PKAI and PKAII
containing Ca2 eluted at comparable concentrations of
NaCl. To further investigate whether human Ca2 forms
PKAI and PKAII in cell extracts we immunoprecipitated
(IPed) with anti-RIa and anti-RIIa (Figure 2). Using
immunoblotting and anti-Ca2 (upper panels) and anti-
pan-C (lower panels) we showed that both RIa and
RIIa associate with Ca2, implying that Ca2 forms PKAI
and II in vivo (lanes 6 and 12). To define whether the
R-C interaction is specific and functional, the IPed pro-
teins were challenged with cAMP to dissociate the
holoenzyme into R subunit dimers and free C subunits
[46]. In these experiments the IPed R subunits would be
expected to be immobilized by the precipitating anti-
serum and remain in the pellet (P) after the cAMP wash
whereas the IPed C subunit would be released into the
supernatant (S) in the presence of cAMP [46;47]. Figure
2 (lanes 3 and 4, and 9 and 10) depicts that immunor-
eactive Ca2 is released into the supernatant after the
cAMP wash (+cAMP) after both anti-RIa and anti-RIIa
IP (upper and lower panels) whereas the immunoreac-
tive Ca2 subunit remained in the pellet (P) in the
absence of cAMP (-cAMP) (Figure 2, lanes 5 and 6 and
11 and 12, upper and lower panels).
Comparable activities of Ca2 and Ca1
Our results and several reports showing that Ca2
associates with both RI and RII subunits [3; 48-50] in a
cAMP-sensitive fashion imply that N-terminal differ-
ences do not interfere with PKA holoenzyme formation..
To further investigate wetherCa2 has activities that dif-
fer from Ca1 we expressed Ca2 using the pREST B
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Figure 1 Ca2 is expressed and associate with RIa and RIIa to
form PKA type I and PKA type II in the whole sperm cell. Panel
A: Protein extracts of T cells (lane 1), total sperm (lane 2), sperm tail
(lane 3) and sperm heads (lane 4) were separated by SDS-PAGE
(12.5% gels) and transferred to PVDF filters for immunoblot analysis.
The filters were incubated with a panC antiserum (anti-Ca (scbt),
1:1000) (upper panel) and an anti-Ca2 antiserum (SNO 101,1:20, see
Methods) (lower panel). Arrows to the left indicates migration of the
molecular weight markers. Arrows on the right indicate the identity
of the C subunits. Panel B: PKA type I and II were eluted from
DEAE-cellulose columns using increasing concentrations of NaCl (0-
400 mM). The eluted fractions were analyzed for specific [3H]-cAMP-
binding (dotted line open square) and C subunit- specific
phosphotransferase activity (dotted line closed circle). Panel C:
Protein fractions eluted from the DEAE columns were separated by
SDS-PAGE (12.5% gels) and transferred to PVDF filters for
immunoblot analysis. The filters were incubated with antibodies to
the C (upper two panels) and R subunits (lower two panels).
Immunoreactive proteins to anti-panC (anti-Ca, scbt, 1:1000) and
anti-Ca2 (SNO 101, 1:20) elute between 64 and 260 mM NaCl.
Immunoreactive proteins to anti-RIa (4D7, 1:200) elute between 64
and 260 mM NaCl and immunoreactive proteins to anti-RIIa (Crl.
1:500) between 170 and 260 mM NaCl. Arrows on the right
indicates the relative molecular mass (kDa) for the respective C and
R subunits.
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vector. First we noted that Ca2 and Ca1 were captured
in the soluble and particulate fractions of the bacteria
lysates, respectively, suggesting differences in solubility
(results not shown). Furthermore, specific activity of
expressed Ca2 was determined to 18 ± 3 units/mg (U/
mg, n = 3) which was notably lower than the specific
activity of expressed Ca1 (28 ± 4 U/mg, Figure 3A).
Taken together this may imply differential features of
Ca1 and Ca2. Based on this and to determine the exact
activities for Ca2 three features were investigated. These
included (i) Ca2’s substrate affinity, (ii) the ability to
form holoenzymes with RI and RII in vitro and (iii) the
Km values for Kemptide and ATP. In the latter case we
found the Km values of Ca2 for Kemptide and ATP to
be 27. 8 ± 2.3 μM and 11.5 ± 0.5 μM, respectively (Fig-
ure 3B and 3C). This is in good agreement with pre-
vious results obtained with expressed Ca1 [7].
We next monitored cAMP-sensitivity of type I and II
PKA holoenzymes containing Ca2 in vitro. To calculate
the accurate cAMP activation constant, PKAI (RIa) and
Figure 2 Ca2 associate with both RIa and RIIa in a cAMP-
dependent manner in sperm cells. Sperm cell extracts were
immunoprecipitated (IPed) with anti-RIa (1:100) and anti-RIIa (1:100).
IPed proteins were separated by SDS-PAGE in 12. 5% gels,
transferred to PVDF filters which were incubated with anti-Ca2
(1:20, upper panels) and a pan C antiserum (anti-Cg (scbt) lower
panels). Immunoreactive proteins which had been IPed (lanes 3-6
and lanes 9-12) were compared to immunoreactive proteins in the
supernatant after the IP (lanes 2 and 8, SIP) and to total input (lanes
1 and 7, Lysates). Cell extracts IPed with anti-RIa and anti-RIIa and
sepharose beads coated with anti-IgG, were centrifuged and the
pellets washed with a buffer with (+cAMP) or without (-cAMP)
cAMP. Washed pellets (P) and the respective supernatants (S) were
analyzed by SDS-PAGE and immunoblotting. Lanes 2 and 8 show
anti-Ca2 immunoreactive proteins left in the supernatants after anti-
RIa and RIIa IP (SIP). Lanes 3 and 9 show anti-Ca2 immunoreactive
proteins in supernatant of cAMP treated IP pellets. Lanes 4 and 10
show anti-Ca2 immunoreactive proteins in IP pellet after treatment
with cAMP. Lanes 5 and 11 show anti-Ca2 immunoreactive proteins
in supernatants of non-treated IP pellets. Lanes 6 and 12 show anti-
Ca2 immunoreactive proteins in untreated IP pellet. Arrows on the
left indicates migration of the molecular weight markers. Arrows on
the right indicate the identity of the C subunit.
A
B
C
Figure 3 Determination of specific activity, Km Kemptide and
ATP for human Ca2. Panel A: Specific activity of expressed Ca2
and Ca1 was determined to 18 ± 3 and 28 ± 4 units/mg,
respectively. Note the lower activity of expressed Ca2 compared to
Ca1. Km values for the PKA specific substrate Kemptide and ATP
were determined by incubating recombinant Ca2 in the presence
of increasing concentrations (1 to 500 μM) of the heptapeptide
Kemptide (panel B) and ATP (panel C). Indirect spectrophotometric
analyses of ATP consumption as measurement for Ca2 activity (see
Methods) indicate a Km for Kemptide of 27.8 ± 2.3 μM (n = 2) and
Km ATP of 11.5 ± 0.5 μM (n = 2), see insets panel B and C.
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PKAII (RIIb) containing Ca2 holoenzymes were incu-
bated with 250 μM Kemptide and 10 mM ATP in the
presence of increasing concentrations of cAMP. Kact
values for cAMP were 120 nM and 460 nM for the
holoenzyme formed with RIa and RIIb, respectively,
showing that PKAI containing Ca2 are nearly 4 fold
more sensitive to cAMP than PKAII containing Ca2
holoenzymes (figure 4A,B). The corresponding values
for holoenzymes formed with myrCa1 were 99 nM
(RIa) and 350 nM (RIIb) (figure 4A,B) again demon-
strating a 4 fold increased sensitivity for the RI holoen-
zyme. This is also in agreement with previous in vitro
results for PKAI and II holoenzymes containing Ca1
[38;51], and the Kact values for mouse PKAI isolated
from sperm cells ablated for PKAII (RIIa) [11]. It should
be noted that Kact in wild type sperm cells which
mainly express PKAII (RIIa-Ca2) [45] is almost identi-
cal to the Kact in RIIa ablated sperm cells. This may
suggest that PKAI and PKAII display comparable Kact’s
in vivo and hence contradicts the in vitro results
demonstrated previously [38] and by us here. It should
also be noted that PKAI although expressed at low
levels may skew the observed Kact values, due to its
sensitivity for cAMP. To what extent this has biological
consequences as has been demonstrated for PKAI and
PKAII in lymphoid cells [27;52;53], remains to be tested.
We then investigated the potency of the R subunits
(RIa, RIIa, RIb and RIIb) and the protein kinase
inhibitor PKIa to inhibit Ca2 phosphotransferase
activity in vitro. Purified Ca2 (30 nM) was mixed with
a fixed concentration of Kemptide (250 μM) in the
presence of increasing concentrations of the various R
subunits or PKIa. All the R subunits inhibited Ca2-
dependent kinase activity by 50% at 15 nM and
showed complete inhibition at a 1:1 molar ratio (Figure
5A and 5B). A fixed dose (28 nM) of Ca2 was inhib-
ited by PKIa in a dose-dependent manner with com-
plete inhibition at stoichiometric concentrations of
Ca2 and PKIa (Figure 5C). The inhibitory effects of
the various R subunits and PKI have previously been
determined for Ca1 [7;29] and indicate that the effi-
ciency in inhibiting Ca1 and Ca2 is similar for all R
subunits and PKIa. Using a Biacore technology we
next investigated the dissociation equilibrium constants
(KD), association (kass) and dissociation (kdiss) rate con-
stants for the various R subunits in association with
either Ca1 or Ca2. We immobilized 300 RUs of myris-
tylated Ca1 (myrCa1, see Methods) and Ca2 on sepa-
rate flow cells of a CM5 Biacore sensor chip.
Unmyristylated Ca1 was used as reference (data not
shown). In the presence of 1 mM ATP and 5 mM
MgCl2 the R subunits were simultaneously run over
both C subunits on the sensor chip at a flow rate of 30
μL/min. In the case of RIa and RIb they were run over
the sensor chip at concentrations between 0.25 and
128 nM, and RIIa and RIIb between 0.5 to 256 nM
(raw data not shown). Figure 6 (panel A) shows repre-
sentative runs of RIa, RIb, RIIa and RIIb (64 nM each;
panel B) on Ca2 and myrCa1. The shape of the curves
indicates that the relative on and off rates for RIa
when associated with either Ca2 or myrCa1 were
highly similar. The relative kass values were slightly dif-
ferent, 1.6 × 106 and 1.9 × 106 M-1s-1 for RIa versus
myrCa1 and Ca2, respectively. The same was true for
RIb. However, in this case, although the KD value was
almost identical to RIa, the association as well as the
dissociation rate constants for RIb was 2 times faster.
Finally, no differences could be observed for the inter-
action of RIIa and RIIb against myrCa1 versus Ca2
(for rate and equilibrium constants see Table 1).
In order to investigate the binding behavior of PKI,
GST-PKIa was immobilized on sensor chips as
described previously [54], and various concentrations of
Ca2, Ca1, myrCa1 and, for comparison, mouse Ca1
were run at a flow rate of 30 μL/min over the sensor
chips. This revealed a KD for all C subunits and PKIa
at a range around 0,4 nM where the myrCa1 displayed
a slightly faster association rate compared to Ca1 (4.9 ×
106 and 3.2 × 106 M-1s-1, respectively) with all the disso-
ciation rates being similar (1.5 × 10-3 s-1) (Table 2). SPR
measurements with single concentrations demonstrated
almost identical shapes of the curves (Figure 7),
A
B
Figure 4 Determination of the activation constant Kact (cAMP)
for Ca2 and myr Ca1 containing PKA type I and II
holoenzymes. PKA type I and II holoenzymes were made by
mixing recombinant Ca2 and myr Ca1, respectively, with either
recombinant RIa (panel A) or RIIb (panel B) in a molar ratio 1: 1.2 (C:
R, see Methods). The holoenzymes were incubated with Kemptide
(250 μM) and increasing concentrations of cAMP (0,1 nM- 10 μM) to
determine the activation constant (Kact). A Kact (cAMP) for RIa-Ca2
and RIa-myrCa1. B Kact (cAMP) for RIIb-Ca2 and RIIb-myrCa1. .
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AB
C
Figure 5 Phosphotransferase activity of Ca2 is inhibited by the R subunits and PKI in dose-dependent manner. Recombinant Ca2 (30 nM)
mixed with Kemptide (250 μM) and ATP (10 mM) was incubated in the presence of increasing concentrations (0 - 25 nM) of either RIa and RIb
(panel A) and RIIa and RIIb (panel B). Ca2 is inhibited by all R subunits in a dose-dependent manner at equimolar concentrations of RIa, RIb, RIIa
and RIIb. Panel C: The inhibitory effect of PKIa was verified by incubating recombinant Ca2 (28 nM) in the presence of Kemptide (250 μM), ATP (10
mM) and increasing concentrations of recombinant PKIa (0-40 nM). Titration curves shown are normalized before linear regression (n = 2).
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indicating comparable association and dissociation rates.
In order to determine accurate association rate con-
stants, different concentrations of the respective C subu-
nits were applied (results not shown), leading again to
the conclusion that the binding activities of Ca2 and
Ca1 for PKIa are highly similar.
Discussion
At the protein level Ca1 and Ca2 are 97% homologous
and only differ at the N-terminal end. Based on this we
investigated to what extent differences at the N-termi-
nus may influence splice variant-specific activities that
may have biological importance. We found that Ca2
expressed in bacteria was not captured by inclusion
bodies as was the case with Ca1. Moreover, the specific
activity of Ca2 was lower compared to Ca1. Apart from
these differences we observed that Ca2 was highly simi-
lar to Ca1 in all parameters measured. This included
association of Ca2 with RI and RII to form cAMP-sensi-
tive holoenzymes both in vivo and in vitro. Furthermore,
Km values of Ca2 for Kemptide and ATP were compar-
able to those determined for Ca1. This was also the
case for the ability of RI, RII and PKI to inhibit Ca2
enzyme activity in vitro (data not shown). Finally, KD
values as measured by SPR were shown to be compar-
able between Ca1 and Ca2 towards the RI and RII sub-
units as well as PKI.
Several reports imply that N-terminal modifications of
Ca1 introduce specific features that may have biological
consequences. To this end it has been suggested that
phosphorylation of Ser10 in Ca1 introduces an electro-
static force which may help the C subunit to remain
soluble even when myristylated [55;56]. Moreover, two
reports have demonstrated that the N-terminal myristyl
moiety of Ca1 is embedded in a hydrophobic pocket
A
B
Figure 6 The affinity of RI and RII subunits for Ca1 and Ca2
are comparable. Ca2 and myrCa1 were immobilized on a CM5
sensor chip each with 300 RUs of on a surface using amine
coupling (see Methods). Then recombinant RIa and RIb (panel A) as
well as RIIa and RIIb (panel B) were run simultaneously over each
Ca surface monitoring the association and dissociation of each R
subunit at a flow rate of 30 μl/min. Association and dissociation
were recorded for 5 min each and the interaction was measured
with R subunits in concentrations ranging from 0.25 nM to 128 nM
and 0.5 nM to 256 nM for type I and type II enzymes (for details see
results), respectively (table 1). All experiments were performed in 20
mM MOPS pH 7, 150 mM NaCl plus 0.005% (v/v) surfactant P20, 1
mM ATP, 5 mM MgCl2 and 50 μM EDTA. The panels show
representative kinetics injecting the four R-isoforms on myrCa1 and
Ca2 as indicated on the normalized plot using 64 nM of each R
subunit.
Table 1 Association and dissociation constants of RI and
RII and Ca1 and Ca2
Analyt/Ligand (immobilized) ka [M
-1s-1] kd [s] KD [nM]
hRIa/PKA-Ca1 myr 1.6E + 6 200,0E-6 0,13
hRIa/PKA-Ca2 1.9E + 6 214,0E-6 0,11
hRIb/PKA-Ca1 myr 3.5E + 6 501,0E-6 0,15
hRIb/PKA-Ca2 4.4E + 6 482,0E-6 0,11
hRIIa/PKA-Ca1 myr 1.0E + 6 469,0E-6 0,48
hRIIa/PKA-Ca2 1.2E + 6 433,0E-6 0,35
hRIIb/PKA-Ca1 myr 0.5E + 6 797,0E-6 1,5
hRIIb/PKA-Ca2 0.9E + 6 793,0E-6 0,9
Table 2 Association and dissociation constants of GST-
PKIa for Ca1 and Ca2
Analyt/Ligand (immobilized) Ka[M
-1S-1] Kd[S] Kd[nM]
GST-PKIa/PKA-Ca1 4.9 × 105 1.5 × 10-3 0.5
GST-PKIa/PKA-Ca2 3.2 × 105 1.5 × 10-3 0.7
Figure 7 PKIa binds almost identical to hCa1, myristylated
hCa1, hCa2 and mCa1. GST-PKIa was captured on an a-GST-
Antibody sensor chip as described [55] to surface density of 300 RU.
All C-subunits (Ca2, Ca1, myristylated Ca1 and, for comparison,
mouse Ca1) were run over the GST-PKIa surface using the assay
conditions as described in figure legend 6 in the presence of 1 mM
ATP and 5 mM MgCl2. The plot shows the normalized binding data
at a concentration of 25 nM C-subunit each.
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encompassed in the large lobe [57;58]. Mutation of Gly1
to Ala rendering the Ca1 non-myristylated, demon-
strated that myristylation was non-essential for confor-
mation and enzyme activation, and was not required for
Ca1 interaction with other proteins including various
substrates and the R subunits [21,59]. The fact that Ca2
is not myristylated and displays comparable activities
with myristylated Ca1 suggests that myristylation is not
essential for catalytic activity, holoenzyme formation
and inhibition by PKI. This is further supported in that
deletion of the entire Ca1 N-terminus did not severely
interfere with catalytic activity and inhibitor binding
despite that deletion caused thermo instability [25]. This
also suggests that the amino acids 2 (Asn) and 10 (Ser)
of Ca1 are not essential for activity a suggestion which
is supported by our results on Ca2.
Ca1 and Cb1 which are 100% identical at the N-ter-
minus, but only 91% identical in the sequence encode
by exon 2 through 10, have different apparent sizes (40
and 41 kDa) and possess distinct biochemical properties
both in vitro and in vivo [60; 31]. These differences
include differential Km values for certain peptide sub-
strates and that Ca1 but not Cb1 is inhibited by sub-
strate concentrations above 100 μM. In addition, they
display distinct IC50 values for PKI and RIIa. Taken
together with our results this may suggest that the
amino acid sequence encoded by exon 2 through 10 and
not exon 1 influence C subunit activities such as
holoenzyme formation, enzyme activity and inhibition
by R and PKI. This may further imply that Ca1 and
Cb1 have distinct roles in regulating cellular processes.
This was recently shown in T cells which express Ca1,
Cb1 and Cb2. In that study Ca1, but none of the Cb
forms, mediated the inhibitory effect of cAMP on
immune cell reactivity in vivo [17;61]. In light of these
observations it is also of interest to note that Ca2 but
not Ca1 is required for sperm cell forward velocity and
male fertility, despite 100% identity at the amino acid
sequence encoded by exon 2 through 10 [20;62]. How-
ever, since Ca2 is the sole C subunit in sperm cells
[9;10;63], the difference observed may only be ascribed
to tissue-specific expression and not sequence-specific
differences.
In contrast to Ca1 it is expected that the hydropho-
bic pocket in which the myristyl group is submersed in
Ca1, is constitutively empty and exposed to the sur-
roundings at all time in non-myristylated Ca2. It has
been speculated whether exposure of the hydrophobic
pocket would introduce more lipophilic properties to
the Ca2 subunit [64]. Support for such a hypothesis is
found in a by a study demonstrating that binding of
Ca1 to RII induced a unique conformation that is
associated with exposure of the hydrophobic pocket to
the surroundings due to increase in N-terminal
flexibility of the N-myristate away from the large lobe.
This renders Ca1 more hydrophobic and promotes
membrane association of the PKA II holoenzyme only
[64]. Therefore it may be suggested that exposure of
the hydrophobic pocket serves features such as isoform
specific features and subcellular localization of the C
subunit. To this end it is interesting to note that Ca2
is associated with the sperm tail in the presence of
detergent treatment with 1% Triton X-100 .and, after a
challenge with 2 mM cAMP [10]. This may be indica-
tive of a direct association of Ca2 with subcellular
structures. To what extent such attachment involves
the hydrophobic pocket remains unknown. In other
cells and tissues, C subunits targeted to subcellular
structures independent of the R subunit and traditional
A-kinase anchoring proteins have been demonstrated.
To day a number of C subunit binding proteins have
been identified. These include PKI, A-kinase interact-
ing protein 1 (AKIP1), homologous to AKAP95
(HA95), inhibitor of NFkappaB kinase (IB), Caveolin-
1 and p75 neutrophine receptor (p75NTR) [65-69]. To
what extent Ca2 is targeted to the sperm cell midpiece
through a C interaction protein and if specificity of
binding is retained in the hyper variable N-terminal
end remains to be shown. However, it should be noted
that deamination of the Asn2 moiety in Ca1 helps
fine-tuning enzyme distribution within the cell in vivo
[70]. Moreover, p75NTR was shown to specifically
bind to the Cb splice variant Cb4ab [69], which is
encoded with unique N-terminal domain that may not
undergo the same posttranslational modifications as
Ca1 [15;69]. Together this may imply that the N-term-
inal end may be important for targeting and specificity
of subcellular localization of the various C subunits.
Conclusion
Our study demonstrates that N-terminal sequence
encoded by alternative use of exons upstream of exon 2
in the PRKACA gene does not influence C subunit
activities such as holoenzyme formation, cAMP sensitiv-
ity, enzyme activity as well as inhibition by RI, RII and
PKI. Based on several studies it may be suggested that
the N-terminus is involved in other C subunit features
such as subcellular localization.
Abbreviations
PKA: Protein kinase A; C: Catalytic subunit; Cα: Alpha-form of C; Cα2: Sperm-
specific C subunit.
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